Rheumatology

Research Activities

Our research missions are:

  1. To develop new and more effective treatments for pediatric rheumatic diseases and better understand their long term outcomes.
  2. To expand and support basic science and translational research into the etiology and pathogenesis of rheumatic diseases.
  3. To encourage and enable patient participation in studies that will further the development of best treatments such that every child with an identifiable rheumatologic disease has the opportunity to participate in a research study.
  4. To develop clinical educator research and technology, improving access to care and education of physicians about pediatric rheumatic disease.

Dr. Carol Wallace
Dr. Wallace's main focus has been the aggressive treatment of Juvenile Idiopathic Arthritis (JIA), definition of remission for JIA and the long term outcome of JIA. She has published many of the sentinel studies of the use of methotrexate in the treatment of JIA. Dr. Wallace is the Principal Investigator of the NIAMS funded clinical study Trial of Early Aggressive Therapy in Juvenile Idiopathic Arthritis (TREAT). She participates in many multicenter clinical trials of new biologic agents for the treatment of JIA. Dr. Wallace is the immediate past Chair of the Childhood Arthritis and Rheumatology Research Alliance (CARRA).

Dr. Anne Stevens
The Stevens Lab is focused on the role of maternal microchimerism and T lymphocyte regulation in children with autoimmune diseases, such as lupus, scleroderma, and juvenile arthritis.

Dr. Kristen Hayward

Dr. Kabita Nanda

Dr. Sarah Ringold

Dr. Peggy Schlesinger

Dr. Susan Shenoi

Dr. Jennifer Turner

For more information on this specialty, please visit the Rheumatology webpage.